Opinion Today: Will Musk & Co. move fast and break our brains?
The New York Times Opinion Today newsletter sent out on April 29, 2025, by Alex Ellerbeck, an Associate Staff Editor in Opinion, discusses the growing involvement of Silicon Valley tech millionaires and billionaires, including Elon Musk, in the psychedelic industry. The newsletter highlights the use of ketamine by Musk and the interest of key figures in the Trump administration in legalizing and using psychedelic substances for medical treatments. It also touches on the concerns raised about the potential risks associated with a hurried approval process of psychedelics by the administration and the impact on the industry's reputation.
Products
The newsletter does not specifically mention any products for sale. However, the focus is on the utilization and potential legalization of psychedelic substances for medical purposes by influential individuals and organizations associated with Silicon Valley and the Trump administration.
Store: nytimes.com
The New York Times domain, nytimes.com, is a well-known and reputable online platform that covers a wide range of topics, including news, opinion pieces, and in-depth analyses. As the store mentioned in the newsletter, The New York Times has a long-standing history of delivering high-quality journalism and engaging content to its readers. The platform provides various subscription options to access exclusive articles, newsletters, and games.
